These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


261 related items for PubMed ID: 27264544

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Association between Ki-67 Labeling index and Histopathological Grading of Glioma in Indonesian Population.
    Theresia E, Malueka RG, Pranacipta S, Kameswari B, Dananjoyo K, Asmedi A, Wicaksono AS, Hartanto RA, Dwianingsih EK.
    Asian Pac J Cancer Prev; 2020 Apr 01; 21(4):1063-1068. PubMed ID: 32334471
    [Abstract] [Full Text] [Related]

  • 24. Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.
    Couldwell WT, Weiss MH, Law RE, Hinton DR.
    J Neurosurg; 1995 Mar 01; 82(3):461-8. PubMed ID: 7861225
    [Abstract] [Full Text] [Related]

  • 25. Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas.
    Yamamoto Y, Ono Y, Aga F, Kawai N, Kudomi N, Nishiyama Y.
    J Nucl Med; 2012 Dec 01; 53(12):1911-5. PubMed ID: 23081994
    [Abstract] [Full Text] [Related]

  • 26. Diagnostic performance of texture analysis on MRI in grading cerebral gliomas.
    Skogen K, Schulz A, Dormagen JB, Ganeshan B, Helseth E, Server A.
    Eur J Radiol; 2016 Apr 01; 85(4):824-9. PubMed ID: 26971430
    [Abstract] [Full Text] [Related]

  • 27. Diffusion kurtosis imaging can efficiently assess the glioma grade and cellular proliferation.
    Jiang R, Jiang J, Zhao L, Zhang J, Zhang S, Yao Y, Yang S, Shi J, Shen N, Su C, Zhang J, Zhu W.
    Oncotarget; 2015 Dec 08; 6(39):42380-93. PubMed ID: 26544514
    [Abstract] [Full Text] [Related]

  • 28. Epidermal Growth Factor Receptor and Ki-67 Expression in Canine Gliomas.
    Fraser AR, Bacci B, le Chevoir MA, Long SN.
    Vet Pathol; 2016 Nov 08; 53(6):1131-1137. PubMed ID: 27154542
    [Abstract] [Full Text] [Related]

  • 29. Analysis of diffusion tensor imaging metrics for gliomas grading at 3 T.
    Server A, Graff BA, Josefsen R, Orheim TE, Schellhorn T, Nordhøy W, Nakstad PH.
    Eur J Radiol; 2014 Mar 08; 83(3):e156-65. PubMed ID: 24457139
    [Abstract] [Full Text] [Related]

  • 30. [Relationship between miR-218 and CDK6 expression and their biological impact on glioma cell proliferation and apoptosis].
    Zhang JM, Sun CY, Yu SZ, Wang Q, An TL, Li YY, Kong YL, Wen YJ.
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul 08; 40(7):454-9. PubMed ID: 22088371
    [Abstract] [Full Text] [Related]

  • 31. Glioma grading by microvascular permeability parameters derived from dynamic contrast-enhanced MRI and intratumoral susceptibility signal on susceptibility weighted imaging.
    Li X, Zhu Y, Kang H, Zhang Y, Liang H, Wang S, Zhang W.
    Cancer Imaging; 2015 Mar 21; 15(1):4. PubMed ID: 25889239
    [Abstract] [Full Text] [Related]

  • 32. Molecular profiles for insular low-grade gliomas with putamen involvement.
    Zhou C, Wang Y, Liu X, Liang Y, Fan Z, Jiang T, Wang Y, Wang L.
    J Neurooncol; 2018 Jul 21; 138(3):659-666. PubMed ID: 29556911
    [Abstract] [Full Text] [Related]

  • 33. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema.
    Server A, Kulle B, Maehlen J, Josefsen R, Schellhorn T, Kumar T, Langberg CW, Nakstad PH.
    Acta Radiol; 2009 Jul 21; 50(6):682-9. PubMed ID: 19449234
    [Abstract] [Full Text] [Related]

  • 34. Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Porto L, Hattingen E, Stuecher A, Herminghaus S, Lanfermann H, Ulrich Pilatus UP.
    J Neurol Surg A Cent Eur Neurosurg; 2012 May 21; 73(3):147-52. PubMed ID: 22190143
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of expressions of cell-cycle regulatory proteins in gastrointestinal stromal tumor and the relevance of the risk grade.
    Nakamura N, Yamamoto H, Yao T, Oda Y, Nishiyama K, Imamura M, Yamada T, Nawata H, Tsuneyoshi M.
    Hum Pathol; 2005 Jul 21; 36(7):828-37. PubMed ID: 16084954
    [Abstract] [Full Text] [Related]

  • 36. Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma.
    Xu G, Li C, Wang Y, Ma J, Zhang J.
    Medicine (Baltimore); 2021 Sep 10; 100(36):e26750. PubMed ID: 34516487
    [Abstract] [Full Text] [Related]

  • 37. Diagnostic performance of perfusion MRI in differentiating low-grade and high-grade gliomas: advanced MRI in glioma, A Siriraj project.
    Direksunthorn T, Chawalparit O, Sangruchi T, Witthiwej T, Tritrakarn SO, Piyapittayanan S, Charnchaowanish P, Pornpunyawut P, Sathornsumetee S.
    J Med Assoc Thai; 2013 Sep 10; 96(9):1183-90. PubMed ID: 24163995
    [Abstract] [Full Text] [Related]

  • 38. Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.
    Ding X, He Z, Zhou K, Cheng J, Yao H, Lu D, Cai R, Jin Y, Dong B, Xu Y, Wang Y.
    J Natl Cancer Inst; 2010 Jul 21; 102(14):1052-68. PubMed ID: 20554944
    [Abstract] [Full Text] [Related]

  • 39. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastases using susceptibility-weighted imaging.
    Ding Y, Xing Z, Liu B, Lin X, Cao D.
    Brain Behav; 2014 Jul 21; 4(6):841-9. PubMed ID: 25365807
    [Abstract] [Full Text] [Related]

  • 40. Correlation of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma.
    Alexiou GA, Zikou A, Tsiouris S, Goussia A, Kosta P, Papadopoulos A, Voulgaris S, Kyritsis AP, Fotopoulos AD, Argyropoulou MI.
    Clin Neurol Neurosurg; 2014 Jan 21; 116():41-5. PubMed ID: 24309151
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 14.